人工智能在药物发现中的未来前景
Mithun Bhowmick1, Sourajyoti Goswami1, Pratibha Bhowmick1
1Bengal College of Pharmaceutical Sciences and Research, Durgapur, West Bengal, India.
Advances in pharmacology (San Diego, Calif.)
|April 2, 2025
概括
人工智能 (AI) 可以通过降低成本和提高成功率来显著改善药物发现和开发. 人工智能加速了候选药物的识别,并优化了临床试验,以更有效地开发治疗方法.
科学领域:
- 制药科学 制药科学
- 计算生物学 计算生物学
- 人工智能在医学中的应用
背景情况:
- 药物发现和开发是一个漫长,昂贵的过程,成功率很低.
- 高额的研发 (R&D) 支出和降低的生产率困扰着制药行业.
- 在识别有效药物和将其推向市场方面的低效率是重大挑战.
研究的目的:
- 调查新药批准率低的原因.
- 探索人工智能 (AI) 的潜力,以增强药物发现和开发.
- 检查实际的AI应用,未来的机遇,方法和制药研究中的实施挑战.
主要方法:
- 使用人工智能算法分析大型数据集.
- 分子相互作用的预测建模.
- 通过人工智能优化临床试验设计.
- 将计算方法与传统制药策略的整合.
主要成果:
- 人工智能可以更有效地识别有前途的候选药物.
- 人工智能有可能降低研发成本,提高药物开发的精度.
- 人工智能集成简化了治疗药物开发管道,提高了效率.
结论:
- 人工智能提供了一种革命性的方法来克服药物发现和开发中的低效率.
- 由人工智能驱动的方法可以显著加快从研究到市场准备的治疗方法的过程.
- 解决实施挑战是充分实现AI在制药创新的潜力的关键.
相关概念视频
Drug Discovery: Overview
7.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.2K
Structure-Activity Relationships and Drug Design
467
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
467
Preclinical Development: Overview
4.1K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.1K
Drug Administration and Therapy Phases: Overview
395
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
395
Principles of Drug Action
5.6K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
5.6K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


